Abstract: A method is provided. The method includes: assigning a buffer to a first wafer lot comprising a plurality of wafers according to a first trigger event associated with an equipment; and assigning a transporter to a second wafer lot comprising a plurality of wafers according to a second trigger event associated with the equipment.

Abstract: A method comprises transferring a wafer carrier to or from an overhead hoist transfer (OHT) system using a conveyor. The method also comprises transferring the wafer carrier between the conveyor and an overhead shuttle (OHS) system using a cross-system transport apparatus. The method further comprises generating control signals using a controller to control at least one of the cross-system transport apparatus, the conveyor, or the loading or unloading of the wafer carrier at the OHT or the OHS. The cross-system transport apparatus comprises a lifting device configured to raise or lower the wafer carrier. The transferring of the wafer carrier between the conveyor and the OHS system comprises one or more of lifting or lowering the wafer carrier.

Abstract: A system comprising a conveyor. A semiconductor processing tool has a lifter port. The tool is positioned near the conveyor, such that the lifter port is configured to transport a Front Opening Unified Pod (FOUP) between the conveyor and the lifter port. An upstream stocker and a downstream stocker are both co-located with the conveyor and the tool. The upstream and downstream stockers each have a respective storage space for the FOUP and a respective robotic device configured to transport the FOUP between its respective storage space and the conveyor. The upstream stocker is configured to receive the FOUP from an overhead transport (OHT) and deliver the FOUP to the conveyor. The downstream stocker is configured to receive the FOUP from the conveyor and deliver the FOUP to the OHT.

Abstract: A method for monitoring a process in a semiconductor processing facility and a monitor system are provided. A plurality of wafers are processed according to a process. Data on the processing is collected, and the collecting includes, for each wafer of the plurality of wafers, determining that a processing event has occurred, and recording a time associated with the processing event. An amount of time between the recorded times is calculated for consecutively processed wafers. A set of control limits for the process is determined based on the calculated amounts of time. The set of control limits define a range of acceptable values for the amount of time. Second wafers are processed according to the process. A problem in the processing of the second wafers is identified based on the set of control limits. The problem is identified as the second wafers are being processed.

Abstract: A system for managing semiconductor production includes a conveyor to convey a wafer carrier to or from an overhead hoist transfer system. The system also includes a cross-system transport apparatus to transfer the wafer carrier between the conveyor and an overhead shuttle system.

Abstract: Systems and methods for composite myocardial elastography are presented. In exemplary embodiments of the present invention an imaging modality field of view, such as, for example, that of ultrasound, can be divided into N sectors, each having 1/Nth of a full field of view. In exemplary embodiments of the present invention a temporal series of 2D ultrasound images for each of the N sectors can be acquired over a duration of one or more periods of a periodic signal. Substantially simultaneously, such a periodic signal can also be acquired, wherein each of said series of 2D ultrasound images for each sector can be triggered using said periodic signal. For example, for ultrasound imaging of the heart, an ECG signal can function as such a periodic signal. The data from the various N sectors can be synchronized in time using the ECG signals, and the ultrasound signals from each of the N sectors combined to generate a series of composite ultrasound images at the frame rate of the individual sectors.

Abstract: A penholder provides a consumer to change by oneself a pattern, color or even model of pan body. The said penholder includes an inner sleeve, at least one outer sleeve and a dismountable fixing cap. The dismountable fixing cap is provided on a top end of the inner sleeve and forms a limiting function to the outer sleeve to prevent it from dropping. Selectively, at least one protruded member is provided on the inner sleeve or the dismountable fixing cap at a place where the inner sleeve or the dismountable fixing cap is abutted at the outer sleeve. Moreover, a recess is provided on an end rim of the outer sleeve to be latched in by the protruded member. Therefore, a penholder is provided, wherein by simply replacing the outer sleeve, a pattern, color or even model of the pen body can be changed.

Abstract: A penholder includes primarily an inner sleeve, at least one outer sleeve and a dismountable fixing cap. An outer wall of the inner sleeve is formed with a step at a place close to a bottom end of the inner sleeve. The at least one outer sleeve is sheathed on an outer layer of the inner sleeve, and a bottom end of the outer sleeve is abutted at the step of the inner sleeve. The dismountable fixing cap is provided on a top end of the inner sleeve and forms a limiting function to prevent the outer sleeve from dropping. Therefore, a penholder is provided, wherein by simply replacing the outer sleeve, a pattern, color or even model of the penholder can be changed.

Abstract: A driving assisting system includes a traffic signal controller, an RSU, at least one data transmission interface and an OBU. The RSU is electrically connected to the traffic signal controller. The OBU is installed on a vehicle. The traffic signal controller controls a traffic light, which is located at an intersection. The RSU obtains traffic-light information of the traffic light from the traffic signal controller. The OBU receives the traffic-light information through the at least one data transmission interface from the RSU. The OBU generates dynamic vehicle information of the vehicle. The OBU determines if the vehicle will be positioned at a key zone of the intersection when the traffic light switches according to the dynamic vehicle information and the traffic-light information. The OBU responds according to a key zone type of the key zone when the vehicle is positioned at the key zone of the intersection.

Abstract: Systems and methods for composite elastography and wave imaging are presented. In exemplary embodiments of the present invention an imaging modality field of view, such as, for example, that of ultrasound, can be divided into N sectors, each having 1/Nth of a full field of view. In exemplary embodiments of the present invention a temporal series of 2D or 3D ultrasound images for each of the N sectors can be acquired over a duration of one or more periods of a periodic signal. Substantially simultaneously, such a periodic signal can also be acquired, wherein each of said series of 2D ultrasound images for each sector can be triggered or gated using said periodic signal. For example, for ultrasound imaging of the heart, an ECG signal can function as such a periodic signal.

Abstract: A penholder includes primarily an inner sleeve, at least one outer sleeve and a dismountable fixing cap. An outer wall of the inner sleeve is formed with a step at a place close to a bottom end of the inner sleeve. The at least one outer sleeve is sheathed on an outer layer of the inner sleeve, and a bottom end of the outer sleeve is abutted at the step of the inner sleeve. The dismountable fixing cap is provided on a top end of the inner sleeve and forms a limiting function to prevent the outer sleeve from dropping. Therefore, a penholder is provided, wherein by simply replacing the outer sleeve, a pattern, color or even model of the penholder can be changed.

Abstract: The present invention provides a method for constructing a fractal network structure in hydrogen storage material to improve the hydrogen uptake at room temperature, the method including the following steps: providing a hydrogen storage material comprising a source and a receptor of hydrogen atoms, wherein the source is disposed above the receptor, and a chemical bridge is disposed between the source and the receptor, wherein the chemical bridge is composed of precursor material; and treating the hydrogen storage material to construct a fractal network structure of mesopores and micropores in the receptor, so as to enhance the hydrogen storage capacity of the hydrogen storage material at room temperature.

Abstract: A system for managing semiconductor production includes a conveyor to convey a wafer carrier to or from an overhead hoist transfer system. The system also includes a cross-system transport apparatus to transfer the wafer carrier between the conveyor and an overhead shuttle system.

Abstract: The present disclosure provides a lithography apparatus. The apparatus includes an exposure module designed for exposure processing; a baking module embedded in the exposure module and designed for post exposure baking (PEB); and a control module designed to control the exposure module and the baking module.

Abstract: The present invention provides novel polynucleotides encoding LTRPC3 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants and splice variants of LTRPC3 polypeptides, LTRPC3b, LTRPC3c, LTRPC3d, LTRPC3e, and LTRPC3f, respectively. Also provided are vectors, host cells, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel LTRPC3, LTRPC3b, LTRPC3c, LTRPC3d, LTRPC3e, and LTRPC3f polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Abstract: A system comprising a conveyor. A semiconductor processing tool has a lifter port. The tool is positioned near the conveyor, such that the lifter port is configured to transport a Front Opening Unified Pod (FOUP) between the conveyor and the lifter port. An upstream stocker and a downstream stocker are both co-located with the conveyor and the tool. The upstream and downstream stockers each have a respective storage space for the FOUP and a respective robotic device configured to transport the FOUP between its respective storage space and the conveyor. The upstream stocker is configured to receive the FOUP from an overhead transport (OHT) and deliver the FOUP to the conveyor. The downstream stocker is configured to receive the FOUP from the conveyor and deliver the FOUP to the OHT.

Abstract: The present invention provides novel polynucleotides encoding LTRPC3g, LTRPC3h, LTRPC3i, LTRPC3j, LTRPC3k, or LTRPC3l polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel LTRPC3g, LTRPC3h, LTRPC3i, LTRPC3j, LTRPC3k, or LTRPC3l polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Abstract: The present invention provides novel polynucleotides encoding human AdipoR2v1 polypeptides, mouse AdipoR2v1 polypeptides, human AdipoR3 polypeptides, human AdipoR2v2 polypeptides, human AdipoR3v1 polypeptides, rat AdipoR1 polypeptides, rat AdipoR2 polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel human AdipoR2v1 polypeptides, mouse AdipoR2v1 polypeptides, human AdipoR3 polypeptides, human AdipoR2v2 polypeptides, human AdipoR3v1 polypeptides, rat AdipoR1 polypeptides, rat AdipoR2 polypeptides, to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Abstract: The present invention provides novel polynucleotides encoding TRP-PLIK2 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants and splice variants of TRP-PLIK2 polypeptides, TRP-PLIK2b, TRP-PLIK2c, and TRP-PLIK2d, respectively. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel TRP-PLIK2, TRP-PLIK2b, TRP-PLIK2c, and TRP-PLIK2d polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Abstract: The present invention provides novel polynucleotides encoding LTRPC3 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants and splice variants of LTRPC3 polypeptides, LTRPC3b, LTRPC3c, LTRPC3d, LTRPC3e, and LTRPC3f, respectively. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing the novel LTRPC3, LTRPC3b, LTRPC3c, LTRPC3d, LTRPC3e, and LTRPC3f polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel LTRPC3, LTRPC3b, LTRPC3c, LTRPC3d, LTRPC3e, and LTRPC3f polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.